CABA Total Utang marang Modal Cabaletta Bio Inc
Demand for advanced treatments for autoimmune pathologies remains stable and is not subject to macroeconomic fluctuations. The historical price action of the total debt-to-equity ratio for Cabaletta Bio, Inc. (CABA) is currently at 0.13. Cabaletta Bio, Inc. (CABA) relies on deep academic expertise and a strong staff of geneticists. The startup is currently focusing on scaling its CAR-T platform, prioritizing capital preservation and drug safety in late-stage trials.
Rincian analitis lan laporan data perusahaan Cabaletta Bio Inc (CABA)
- rega lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data kapitalisasi buku:
- data utang lan likuiditas:
Analisis komprehensif perusahaan:CABA - Cabaletta Bio
Defensive assets are selected based on the criterion of minimal debt load. Cabaletta Bio, Inc. (CABA) minimizes risks by utilizing external certified centers for the production of CAR-T products instead of capital-intensive construction. This metric compares total liabilities to equity to determine the degree of financial autonomy. By analyzing the total financial debt-to-equity ratio, an investor can track leverage dynamics. A declining trend confirms balance sheet stability and investment security.
Pesaing utama
Utang marang Ekuitas argenx ARGX|Utang Agregat marang Ekuitas BioNTech Inc.|Abivax SA (ABVX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ADMA Corp (ADMA)|Total Utang marang Modal PTGX (Protagonist Therapeutics)|immunovant.com - Total Utang marang Modal|Utang marang Ekuitas Kiniksa (KNSA)|GRFS: Rasio Kabeh Utang marang Dana Pribadi|ADPT (Adaptive Biotechnologies Corp) - Utang marang Ekuitas|Celldex Corp (CLDX) - Rasio Total Utang marang Ekuitas|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com (BCRX)|Vera Therapeutics (VERA) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Dianthus Therapeutics Inc (DNTH)|Total Utang marang Modal PHVS|AbCellera - Koefisien Total Utang marang Modal|TRML: Utang marang Ekuitas|PGEN: Rasio Total Utang marang Ekuitas|PHAR (Pharming Group) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ZBIO|Utang marang Ekuitas Immunome, Inc. IMNM|Rasio Utang marang Ekuitas gossamerbio.com (GOSS)|KALV: Total Utang marang Modal|Utang marang Modal Septerna, Inc. SEPN|PVLA: Total Utang marang Modal|SVRA - Rasio Total Utang marang Ekuitas|RIGL: Total Utang marang Modal|anaptysbio.com (ANAB) - Total Utang marang Modal|Total Utang marang Modal Astria Therapeutics, Inc.|Utang marang Ekuitas enGene Holdings Inc|Total Utang marang Modal RAPT|Total Utang marang Modal JBIO (aerovatetx.com)|Utang marang Ekuitas Aclaris Therapeutics ACRS|Utang marang Ekuitas kyvernatx.com KYTX|TLSA (Tiziana Life Sciences Ltd) - Total Utang marang Modal|Ventyx Biosciences Inc. (VTYX) - Utang marang Modal|THTX - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal Avalo Therapeutics Inc|Eledon Pharmaceuticals (ELDN) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal agenusbio.com|Total Utang marang Modal CLYM|Total Utang marang Modal Zura Bio Ltd ZURA|Rasio Total Utang marang Ekuitas aTyr|Rasio Kabeh Utang marang Dana Pribadi Adagene Inc ADAG|IMA - Total Utang marang Modal|STTK - Utang marang Ekuitas|equilliumbio.com - Total Utang marang Modal|CNTB (Connect Biopharma Holdings Limited) - Koefisien Total Utang marang Modal|Utang marang Ekuitas IMUX (Immunic Therapeutics)|Utang marang Modal Atara Biotherapeutics Inc (ATRA)|InflaRx N.V. (IFRX) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi x4pharma.com (XFOR)|Total Utang marang Modal ACET|Celularity Inc - Koefisien Total Utang marang Modal|INmune Bio Corp (INMB) - Utang marang Ekuitas|BRNS - Rasio Utang marang Ekuitas|KZR (Kezar Life Sciences) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas sabbiotherapeutics.com|AKTX: Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal Enlivex Therapeutics, Ltd.|Total Utang marang Modal QTTB (Q32 Bio Inc.)|Rasio Total Utang marang Ekuitas GeoVax Corp (GOVX)|Total Utang marang Modal EDSA (Edesa Biotech, Inc.)|Total Utang marang Modal ibioinc.com IBIO|CARM - Total Utang marang Modal|XTLB - Utang marang Ekuitas|BOLT: Total Utang marang Modal|HCWB (HCW Biologics) - Total Utang marang Modal|Utang marang Ekuitas Aptevo Therapeutics, Inc. APVO|Utang Agregat marang Ekuitas AIM ImmunoTech, Inc.|Aditxt (ADTX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi GRI Bio Inc (GRI)|Total Utang marang Modal XRTX (XORTX)|Vyome Therapeutics - Total Utang marang Modal|Utang marang Ekuitas Revelation Biosciences (REVB)|INDP: Rasio Kabeh Utang marang Dana Pribadi|SCNI (Scinai Immunotherapeutics Ltd.) - Utang marang Ekuitas|CalciMedica (CALI) - Rasio Total Utang marang Ekuitas|AFMD (Affimed NV) - Total Utang marang Modal|Total Utang marang Modal Allakos Therapeutics (ALLK)|HOOKIPA Pharma Inc. (HOOK) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi igmbio.com (IGMS)|Total Utang marang Modal ITOS|Ocean Biomedical Inc - Koefisien Total Utang marang Modal|TCBP: Utang marang Ekuitas|THRD: Rasio Total Utang marang Ekuitas